SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Oct 19, 2022

2. SEC Identification Number

CS200251064

3. BIR Tax Identification No.

219075614

4. Exact name of issuer as specified in its charter

MEDILINES DISTRIBUTORS INCORPORATED

5. Province, country or other jurisdiction of incorporation

Metro Manila, Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

3rd Floor, Vitamall Hub, C.V. Starr Ave., Pamplona Dos, Las Pinas City Postal Code 1740

8. Issuer's telephone number, including area code

+6377471076/+6385192012

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	2,750,000,800

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC

PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Approval of MEDIC Share Buyback Program
Background/Description of the Disclosure
On October 19, 2022, the Board of Directors of Medilines Distributors Incorporated ("Board") approved the creation and implementation of a share buyback program involving up to Philippine Pesos: One Hundred Million (Php 100,000,000.00) worth of the Company's common shares, with the following terms and conditions: a. The objectives of the share buyback program are to enhance shareholder value and to manifest confidence in the Company's value and prospects through the repurchase of the common shares of the Company; b. Subject to appropriate disclosures to the Philippine Stock Exchange ("PSE") and the Securities and Exchange ("SEC"), the share buyback shall commence and shall end upon utilization of the above mentioned amount, or as may otherwise be determined by the Board; c. Mr. Virgilio B. Villar, Chairman, and/or Mrs. Ma Patricia Dolor V. Yambing, President and CEO, have been authorized by the Board to implement the program and approve settlement instructions in relation to the buyback; d. The share buyback program will not affect any of the Company's prospective and existing projects and investments; and e. Any significant development in the share buyback program will be duly disclosed to the SEC and the PSE.
Other Relevant Information
Please see attached 17-C